Skip to main content

Tweets

EUSTAR Study had 1451 systemic sclerosis (SSc) pts enrolled & 706 had complete data. Predictors of #SSc worsening included age, active digital ulcers, lung fibrosis, muscle weakness and elevated C-reactive protein level. https://t.co/QepC6I0HLm

Dr. John Cush @RheumNow ( View Tweet )

7 years ago
18 mos study of 78 patients with ANCA Assoc Vasculitis showed baseline IL-6 levels correlate with PR3-ANCA (not MPO) titers; while assoc w/ certain Sxs (fever, pulm nodules/cavities), deafness, RBC casts; sIL6 levels did not predict responses at 6 mos https://t.co/jawVLOSQnZ

Dr. John Cush @RheumNow ( View Tweet )

7 years ago
Dannish MRI study of 204 people (including 41 #AxSpA) shows that sacroiliac bone marrow edema is nonspecific, seen in 3-39% of non-SpA. Only SI erosions erosions, backfill & ankylosis were specific for axSpA. Few women w/ postpartum pain had SI erosion https://t.co/7iMaKGEafJ

Dr. John Cush @RheumNow ( View Tweet )

7 years ago
Weight loss does not reduce #RA risk. Swedish Obese (SOS) study followed 2002 bariatric surgery pts & 2034 controls. Overall 92 developed RA; RA risk now lower w/ bariatric surgery (HR 0.92; CI 0.59, 1.46) nor did wt loss; but CRP & smoking were https://t.co/bFKiPWvKRQ

Dr. John Cush @RheumNow ( View Tweet )

7 years ago
Study from National Inpatient Sample (2002-11) , 424 hospitals, 4024 #SLE pts admitted w/ sepsis. Mortality varied from 0-60%. Hospitals that treated ⩾3.9 patients with SLE and sepsis annually had a lower risk of lupus mortality (10% vs 17%; P = 0.004). https://t.co/TuVfaGUpcM

Dr. John Cush @RheumNow ( View Tweet )

7 years ago
Mayo Clinic study shows that once #RA is diagnosed with CHF, hospitalization rates were significantly higher in RA vs non-RA (RR 1.17; CI 1.08-1.26). RA \more likely to be hospitalized for non-cardiovascular (RR 1.26); not for CHF or other CV causes. https://t.co/r5fvygpAE9

Dr. John Cush @RheumNow ( View Tweet )

7 years ago
40 years since the "House of God" by Samuel Shem, Dr. Len Calabrese's recollects on the books 40th anniversary. Join his summer book club and add some commentary! https://t.co/L8wiGpWk42

Dr. John Cush @RheumNow ( View Tweet )

7 years ago
Nearly half of Americans believe that the U.S. health care and health care providers are not compassionate. Studies show less than half of physicians and clergy exhibit compassion. (from COMPASSIONOMICS by Trseciak & Mazzarelli) https://t.co/z0F7Ql5oR3

Dr. John Cush @RheumNow ( View Tweet )

7 years ago
The RheumNow Podcast is up! Discussions on MDA-5 Abs & DM; gout & narcotics; IA capsaicin in OA; and ADA vs UPA. Watch here>> https://t.co/gZRJ2eHCqB or listen on iTunes or SoundCloud>> https://t.co/x6mCEqg6gU

Dr. John Cush @RheumNow ( View Tweet )

7 years ago
FDA has approved Otezla 30 mg bid for adults with oral ulcers associated with Behcet's Disease; based on the results showing apremilast lowers the number and pain of oral ulcers in a 12-week placebo-controlled Phase 3 study https://t.co/QeIXxsHxtY

Dr. John Cush @RheumNow ( View Tweet )

7 years ago
FDA has approved Otezla 30 mg bid for adults with oral ulcers associated with Behcet's Disease; based on the results showing apremilast lowers the number and pain of oral ulcers in a 12-week placebo-controlled Phase 3 study. https://t.co/QeIXxsHxtY

Dr. John Cush @RheumNow ( View Tweet )

7 years ago
Canadian study shows the estimated annual cost of inappropriate B12 prescribing was $45.6 million, assuming a 64% inappropriate prescription rate. Only 1.7% of prescribed intramuscular B12 demonstrated any deficiency with a malabsorptive indication https://t.co/yYW9oDjjPZ

Dr. John Cush @RheumNow ( View Tweet )

7 years ago
Mayo study comparing 429 Gout patients in 1990 and 2010 shows less 1st time Podagra 74% to 59% (p<0.001) and 24% higher flare rates in 2010. Predictors of future flares were hyperuricemia (HR 1.59) and CKD (HR 1.34) https://t.co/ZCgCzO7dUs

Dr. John Cush @RheumNow ( View Tweet )

7 years ago
There was no increaesd risk of cancer in 767 patients with giant cell arteritis in western Norway was compared to matched controls https://t.co/25gf89Ty0f

Dr. John Cush @RheumNow ( View Tweet )

7 years ago
anti-MDA5+ amyopathic dermatomyositis (ADM) with ILD is severe and refractory. NEJM letter reports on 18 ADM Rx w/ tofacitinibs who showed better 6 mo survival (100% vs 78%) (P=0.04) and improved ferritin, FVC, DLCO, & CT Chest over time. https://t.co/lsVGPxChoO

Dr. John Cush @RheumNow ( View Tweet )

7 years ago
×